Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda ( BRAINSAFE-II )

NCT04750707 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
270
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Global Health Uganda LTD

Collaborators